Primrose Bio attended the 22nd Annual PEGS Boston Summit in Boston, showcasing how the Pfenex Expression Technology® platform supports complex protein production, site-specific conjugation, streamlined protein recovery, and VHH-ADC development.
Where we presented:
Luncheon Presentation
Diane Retallack, PhD, President & COO
“Streamlining Discovery and Development Workflows Using Engineered P. fluorescens Strains for ncAA Incorporation and Extracellular Protein Production”
Monday, May 11 | 12:10 PM
Scientific Poster A083
Russell Coleman, Director, Strain Engineering
“Preclinical Development of a VHH-ADC Using the Pfenex Platform”
Monday, May 11, 5:55 PM – Tuesday, May 12, 2:20 PM
Booth #624, Ensemble Ballroom
Louis J. Cantolupo, Alec Tzianabos, and the Primrose Bio team were on hand to connect.
